Source fact
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
0001090872-26-000064
Health Care · A
Agilent Technologies
Reported results, filing history, and direct access to the source documents.
LATEST QUARTERLY REPORT
10-Q · Period ended 2026-07-31
Filed 2026-09-01. Values below belong to this filing, not a rolling twelve-month estimate. Duration figures may cover a full year or year-to-date period.
Source fact
us-gaap:NetIncomeLoss
0001090872-26-000064
Source fact
us-gaap:Assets
0001090872-26-000064
Source fact
us-gaap:NetCashProvidedByUsedInOperatingActivities
0001090872-26-000064
LATEST ANNUAL REPORT
10-K · Period ended 2025-10-31
Filed 2025-12-22. Values below belong to this filing, not a rolling twelve-month estimate. Duration figures may cover a full year or year-to-date period.
Source fact
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
0001090872-25-000087
Source fact
us-gaap:NetIncomeLoss
0001090872-25-000087
Source fact
us-gaap:Assets
0001090872-25-000087
Source fact
us-gaap:NetCashProvidedByUsedInOperatingActivities
0001090872-25-000087
Disclosure timeline
Latest tracked 10-K, 10-Q, amendments, and earnings-related 8-K Item 2.02 filings. Amendments are listed but do not automatically replace the original report's facts.
10-Q · Period ended 2026-07-31 →Accession 0001090872-26-000064
8-K · Results of operations disclosure →Accession 0001090872-26-000062
10-Q · Period ended 2026-04-30 →Accession 0001090872-26-000055
8-K · Results of operations disclosure →Accession 0001090872-26-000052
10-Q · Period ended 2026-01-31 →Accession 0001090872-26-000023
8-K · Results of operations disclosure →Accession 0001090872-26-000015
10-K · Period ended 2025-10-31 →Accession 0001090872-25-000087
8-K · Results of operations disclosure →Accession 0001090872-25-000070
10-Q · Period ended 2025-07-31 →Accession 0001090872-25-000036
8-K · Results of operations disclosure →Accession 0001090872-25-000034
10-Q · Period ended 2025-04-30 →Accession 0001090872-25-000021
8-K · Results of operations disclosure →Accession 0001090872-25-000013
10-Q · Period ended 2025-01-31 →Accession 0001090872-25-000008
8-K · Results of operations disclosure →Accession 0001090872-25-000003
10-K · Period ended 2024-10-31 →Accession 0001090872-24-000049
8-K · Results of operations disclosure →Accession 0001090872-24-000042
10-Q · Period ended 2024-07-31 →Accession 0001090872-24-000033
8-K · Results of operations disclosure →Accession 0001090872-24-000024
10-Q · Period ended 2024-04-30 →Accession 0001090872-24-000021
8-K · Results of operations disclosure →Accession 0001090872-24-000017
10-Q · Period ended 2024-01-31 →Accession 0001090872-24-000011
8-K · Results of operations disclosure →Accession 0001090872-24-000006
10-K · Period ended 2023-10-31 →Accession 0001090872-23-000020
8-K · Results of operations disclosure →Accession 0001090872-23-000018
Read with context.
These are automatically extracted filing facts, not a complete financial review. Different companies and report types may use different reporting periods and accounting definitions. Missing values are not zero. No stock prices, earnings forecasts, or buy/sell ratings are provided.
All SEC filings for this company · Sources, coverage, and methodology
For education and research only. Not investment advice. Verify original filings before making decisions.